专利详细信息
专利号 | US2012263716A1 |
专利标题 | METHOD OF TREATING CANCERS AND A PHARMACEUTICAL COMPOSITION THAT MAY BE USED IN PRACTICING SAID METHOD |
专利权人 | DAIICHI SANKYO CO LTD [JP]; |
发明人 | FUJIWARA KOSAKU [JP]; SHIMAZAKI NAOMI [JP]; |
申请号 | US201213527002 |
申请日 | 2012/6/19 |
公开日 | 2012/10/18 |
优先权号 |
JP20060031791 20060209 US20080221019 20080730 WO2007JP52178 20070208 |
IPC | A61K0031427; A61K003144; A61K0031502; A61K0031517; A61K00315377; A61K0039395; A61P003500; A61P003502; |
专利类型 | |
法律状态查询 | 查看法律状态 |
The method of treating a person having a cancer selected from carcinoma, sarcoma or hematopoietic cancer by administering (a) an effective amount of at least one anti-cancer drug selected from the group consisting of an epidermal growth factor receptor (EGFR) inhibitor, a vascular endothelial growth factor receptor (VEGFR) inhibitor and a Raf kinase inhibitor and (b) an effective amount of 5-(4-(6-(4-amino-3,5-dimethyl-phenoxy)-1-methyl-1H-benzimidazol-2-ylmethoxy)-benzyl)-thiazolidine-2,4-dione.dihydrochloride provided that said carcinoma is not lung cancer when an EGFR inhibitor is erlotinib. The invention also provides a pharmaceutical composition that may be used in practicing said method.
专利号 | 专利名称 | 专利权人 | 优先权号 |
---|---|---|---|
NZ570381A | Anti-cancer pharmaceutical composition | DAIICHI SANKYO CO LTD; | JP20060031791 WO2007JP52178 |
没有相关的数据
暂无附图
注:除CN专利外,本系统默认提供的所有其他中文标题和摘要来自机器翻译。